Tevogen Bio Holdings Inc. Common Stock (TVGN)
Tevogen Bio Holdings Inc. (TVGN) is a biopharmaceutical company focused on developing innovative therapies, including vaccines and treatments for infectious diseases. The company aims to leverage scientific advancements to address unmet medical needs through its research and development efforts.
Company News
Tevogen expressed gratitude to HHS for addressing Long COVID, highlighting its investigational drug TVGN 489 as a potential treatment for the approximately 20 million Americans affected by the condition.
The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.